Neuropsychiatric reaction induced by abacavir.
Colebunders
Robert
R
Hilbrands
Robert
R
De Roo
Ann
A
Pelgrom
Jolanda
J
D000328:Adult; D000855:Anorexia / Q000139:chemically induced; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001007:Anxiety / Q000139:chemically induced; D002490:Central Nervous System / Q000187:drug effects*; D003863:Depression / Q000139:chemically induced; D015224:Dideoxynucleosides / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006212:Hallucinations / Q000139:chemically induced; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced*; D008881:Migraine Disorders / Q000139:chemically induced; D019964:Mood Disorders / Q000139:chemically induced; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D012893:Sleep Wake Disorders / Q000139:chemically induced; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir